Skip to main content
    S

    STAAR Surgical Company (STAA)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $26.01
    -0.38 (-1.44%)

    Market Cap: $1.32B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    STAAR Surgical Company (STAA) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect STAAR Surgical Company (STAA) to earn $0.93 per share in the fiscal year ending Dec 31, 2026, on revenue of $338.94M. Of 11 analysts, 4 rate the stock Buy or Strong Buy, 6 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 3 estimates for the fiscal year ending Dec 31, 2026 were revised up and 4 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 11 ratings average 2.73, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 36% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy436.4%
    Hold654.5%
    Sell19.1%
    Strong Sell00.0%
    Consensus
    Hold
    Total analysts
    11

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 21.5% and revenue estimates rise 8.2%.

    Fiscal year ending Dec 31, 2026
    $0.93
    EPS consensus, revenue $338.94M
    Fiscal year ending Dec 31, 2027
    $1.13
    EPS consensus, revenue $366.60M

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.93$0.82 to $1.074$338.94M$333.99M to $346.90M9
    Dec 31, 2027$1.13$1.06 to $1.194$366.60M$332.00M to $384.70M11

    Quarterly Estimates

    The EPS consensus rises from -$0.06 for the quarter ending Dec 31, 2026 to $0.35 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.06-$0.13 to $0.0012$69.72M$62.25M to $79.10M12
    Mar 31, 2027$0.35$0.29 to $0.413$101.58M$94.20M to $105.10M7

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 4 upward and 5 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202634
    Fiscal year ending Dec 31, 202701
    Quarter ending Mar 31, 202710

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 25.7% from $0.74.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$0.93$0.84$0.84$0.76$0.74+26.1%
    Fiscal year ending Dec 31, 2027$1.13$1.11$1.11$1.02$0.99+14.5%
    Quarter ending Mar 31, 2027$0.35$0.37$0.37$0.32$0.29+18.7%

    Frequently Asked Questions About STAA

    What is the STAA stock forecast?

    Consensus analyst estimates put STAAR Surgical Company's EPS at $0.93 for the fiscal year ending Dec 31, 2026, on revenue of $338.94M. The consensus rating from 11 analysts is Hold.

    How do analysts rate STAA stock?

    Of 11 analysts covering STAAR Surgical Company, 0 rate it Strong Buy, 4 Buy, 6 Hold, 1 Sell and 0 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from STAA next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.93, with estimates from $0.82 to $1.07 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.13, with estimates from $1.06 to $1.19 from 4 analysts.

    What revenue do analysts expect from STAAR Surgical Company next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $338.94M, with estimates from $333.99M to $346.90M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $366.60M, with estimates from $332.00M to $384.70M.

    How many analysts cover STAA?

    11 analysts rate STAAR Surgical Company stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.